Back to BlackRock, Inc. BlackRock, Inc.

CRBPCRBP
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CORBUS PHARMACEUTICALS HOLDINGS INC

Yes. BlackRock holds 1,331,135 shares of CRBP (Corbus Pharmaceuticals Holdings), worth $12.5M, as of its Q2 2026 13F filing. It increased the position from 271,636 shares in Q1 2026. BlackRock has held CRBP in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$12.5M

Current Shares

1.3M

Total Value Change

-$4.1M

Total Shares Change

+528,414

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+390.0%
$12.5M0.0%$9.38
45
2026-Q1
Increased
271,636
+1.3%
$2.6M0.0%$9.39
18
2025-Q4
Increased
268,046
+18.1%
$2.2M0.0%$8.14
21
2025-Q3
Decreased
226,898
-35.6%
$2.9M0.0%$12.65
0
2025-Q2
Decreased
352,409
-58.4%
$2.4M0.0%$6.90
0
2025-Q1
Decreased
846,062
-3.1%
$4.5M0.0%$5.31
0
2024-Q4
Increased
873,374
+8.8%
$10.3M0.0%$11.80
30
2024-Q3
First report
802,721
-
$16.6M0.0%$20.63
0

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used